{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:00:10Z","timestamp":1774306810426,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["YSS\/2014\/000106"],"award-info":[{"award-number":["YSS\/2014\/000106"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.intimp.2020.107181","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T17:29:18Z","timestamp":1606325358000},"page":"107181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Leishmanial CpG DNA nanovesicles: A propitious prophylactic approach against visceral leishmaniasis"],"prefix":"10.1016","volume":"90","author":[{"given":"Rohit Kumar","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragya","family":"Chandrakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chhedi Lal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzma","family":"Sayyed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafia","family":"Shekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.107181_b0005","unstructured":"WHO. Leishmaniasis: WHO Fact Sheet. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/leishmaniasis."},{"issue":"3","key":"10.1016\/j.intimp.2020.107181_b0010","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4269\/ajtmh.2010.09-0345","article-title":"Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in Bihar, India","volume":"83","author":"Topno","year":"2010","journal-title":"Am. J. Tropical Med. Hygiene"},{"issue":"1","key":"10.1016\/j.intimp.2020.107181_b0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2229-5070.175023","article-title":"Leishmaniasis: Path toward elimination from the Indian subcontinent","volume":"6","author":"Karunaweera","year":"2016","journal-title":"Tropical Parasitol."},{"key":"10.1016\/j.intimp.2020.107181_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/617521","article-title":"Drug resistance in visceral leishmaniasis","volume":"2010","author":"Maltezou","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107181_b0025","article-title":"Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg\/kg liposomal amphotericin B (Ambisome) in Bihar, India","volume":"8","author":"Burza","year":"2014","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"4","key":"10.1016\/j.intimp.2020.107181_b0030","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI116341","article-title":"Cytokine patterns in the pathogenesis of human leishmaniasis.","volume":"91","author":"Pirmez","year":"1993","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.intimp.2020.107181_b0035","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical and experimental advances in treatment of visceral leishmaniasis","volume":"45","author":"Murray","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9496","key":"10.1016\/j.intimp.2020.107181_b0045","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.intimp.2020.107181_b0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-3083.2005.01686.x","article-title":"Immune response in human visceral Leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome","volume":"62","author":"Peruhype-Magalhaes","year":"2005","journal-title":"Scand. J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2020.107181_b0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.micres.2012.01.002","article-title":"Toll-like receptor signaling: a perspective to develop vaccine against leishmaniasis","volume":"167","author":"Singh","year":"2012","journal-title":"Microbiol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2020.107181_b0060","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/IAI.01090-07","article-title":"Toll-like receptors and Leishmaniasis","volume":"76","author":"Tuon","year":"2008","journal-title":"IAI"},{"key":"10.1016\/j.intimp.2020.107181_b0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/9781681083377118030007","article-title":"Endosomal toll-like receptors: rheostats of inflammation and diseases","volume":"3","author":"Gupta","year":"2018","journal-title":"Front. Clin. Drug Res.-Anti-Allergy Agents"},{"issue":"4","key":"10.1016\/j.intimp.2020.107181_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094596","article-title":"Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis","volume":"9","author":"Shivahare","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.intimp.2020.107181_b0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.exppara.2011.07.007","article-title":"Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis","volume":"129","author":"Tafaghodi","year":"2011","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107181_b0080","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2015.02.121","article-title":"Cross talk between Leishmania donovani CpG DNA and toll-like receptor 9: an immunoinformatics approach","volume":"459","author":"Gupta","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.intimp.2020.107181_b0085","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1073\/pnas.1319268111","article-title":"Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist","volume":"111","author":"Kobiyama","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.107181_b0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.vaccine.2017.11.053","article-title":"Designing an immunocyte-targeting delivery system by use of beta-glucan","volume":"36","author":"Miyamoto","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2020.107181_b0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4049\/jimmunol.0900265","article-title":"Immunization with the DNA-Encoding N-terminal domain of proteophosphoglycan of leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis","volume":"183","author":"Samant","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107181_b0100","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1021\/bm0611937","article-title":"Ternary complex consisting of DNA, polycation, and a natural polysaccharide of schizophyllan to induce cellular uptake by antigen presenting cells","volume":"8","author":"Takeda","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.intimp.2020.107181_b0105","article-title":"Organosulphur compounds induce apoptosis and cell cycle arrest in cervical cancer cells via downregulation of HPV E6 and E7 oncogenes","volume":"20","author":"Ansari","year":"2020","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2020.107181_b0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ijpara.2012.02.013","article-title":"A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis","volume":"42","author":"Gupta","year":"2012","journal-title":"Int. J. Parasitol."},{"issue":"15","key":"10.1016\/j.intimp.2020.107181_b0115","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2005.12.053","article-title":"Leishmania donovani: Identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis","volume":"24","author":"Garg","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.intimp.2020.107181_b0120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/jac\/dkr485","article-title":"Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses","volume":"67","author":"Gupta","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.intimp.2020.107181_b0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cimid.2012.09.004","article-title":"Recombinant translation initiation factor-1 of Wolbachia is an immunogenic excretory secretory protein that elicits Th2 mediated immune protection against Brugia malayi","volume":"36","author":"Nag","year":"2013","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2020.107181_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035670","article-title":"Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein\/vaccine candidate against visceral Leishmaniasis","volume":"7","author":"Kushawaha","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2020.107181_b0135","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00436-007-0861-8","article-title":"Prior killing of intracellular bacteria Wolbachia reduces inflammatory reactions and improves antifilarial efficacy of diethylcarbamazine in rodent model of Brugia malayi","volume":"102","author":"Shakya","year":"2008","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.107181_b0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coi.2009.01.003","article-title":"Pattern recognition: recent insights from Dectin-1","volume":"21","author":"Reid","year":"2009","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107181_b0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.molimm.2004.06.019","article-title":"Mechanisms promoting dendritic cell-mediated transmission of HIV","volume":"42","author":"Wilflingseder","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2020.107181_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107181_b0155","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0769-2625(87)80036-3","article-title":"Identification of T-cell-reactive antigens that protect BALB\/c mice against Leishmania major","volume":"138","author":"Scott","year":"1987","journal-title":"Annales de l'Institut Pasteur\/Immunologie"},{"issue":"2","key":"10.1016\/j.intimp.2020.107181_b0160","first-page":"318","article-title":"Serological investigations on Indian kala-azar","volume":"40","author":"Ghose","year":"1980","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107181_b0165","first-page":"173","article-title":"Cytokine-producing T cell subsets in human leishmaniasis","volume":"48","author":"Kemp","year":"2000","journal-title":"Archivum Immunologiae Therapiae Exp.-Engl. Ed."},{"issue":"3","key":"10.1016\/j.intimp.2020.107181_b0170","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/iai.61.3.1069-1073.1993","article-title":"Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis","volume":"61","author":"Kemp","year":"1993","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.intimp.2020.107181_b0175","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"Liew","year":"1990","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107181_b0180","first-page":"570","article-title":"Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis","volume":"69","author":"Liew","year":"1990","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.intimp.2020.107181_b0185","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.66.5.2135-2142.1998","article-title":"Cloning of Syrian Hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral Leishmaniasis","volume":"66","author":"Melby","year":"1998","journal-title":"Infect. Immun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:45:42Z","timestamp":1762551942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920336481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":36,"alternative-id":["S1567576920336481"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107181","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leishmanial CpG DNA nanovesicles: A propitious prophylactic approach against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107181"}}